These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 29227418)
1. Development and Validation of Surveillance-Based Algorithms to Estimate Hepatitis C Treatment and Cure in New York City. Moore MS; Bocour A; Jordan L; McGibbon E; Varma JK; Winters A; Laraque F J Public Health Manag Pract; 2018; 24(6):526-532. PubMed ID: 29227418 [TBL] [Abstract][Full Text] [Related]
2. A Surveillance-Based Hepatitis C Care Cascade, New York City, 2017. Moore MS; Bocour A; Laraque F; Winters A Public Health Rep; 2018; 133(4):497-501. PubMed ID: 29902392 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of a hepatitis C clinical care coordination programme's effect on treatment initiation and cure: A surveillance-based propensity score matching approach. Deming R; Ford MM; Moore MS; Lim S; Perumalswami P; Weiss J; Wyatt B; Shukla S; Litwin A; Reynoso S; Laraque F J Viral Hepat; 2018 Nov; 25(11):1236-1243. PubMed ID: 29757491 [TBL] [Abstract][Full Text] [Related]
4. Field investigations of emergency department syndromic surveillance signals--New York City. Steiner-Sichel L; Greenko J; Heffernan R; Layton M; Weiss D MMWR Suppl; 2004 Sep; 53():184-9. PubMed ID: 15717390 [TBL] [Abstract][Full Text] [Related]
5. Check Hep C: A Community-Based Approach to Hepatitis C Diagnosis and Linkage to Care in High-Risk Populations. Ford MM; Jordan AE; Johnson N; Rude E; Laraque F; Varma JK; Hagan H J Public Health Manag Pract; 2018; 24(1):41-48. PubMed ID: 28141668 [TBL] [Abstract][Full Text] [Related]
6. Estimating the prevalence of chronic hepatitis C virus infection in New York City, 2015. Bocour A; Greene SK; Laraque F; Winters A Epidemiol Infect; 2018 Sep; 146(12):1537-1542. PubMed ID: 29932040 [TBL] [Abstract][Full Text] [Related]
7. Use of Capture-Recapture Analysis to Assess Reporting Completeness of Births to Hepatitis B-Positive Women in New York City, 2013-2014. Devinney K; Lazaroff J; Rosen JB; Zimmerman CM; Zucker JR Public Health Rep; 2020; 135(3):322-328. PubMed ID: 32267800 [TBL] [Abstract][Full Text] [Related]
8. Detection of Recurrent Hepatitis C Viremia Using Surveillance Data, New York City. Guerra K; Bocour A; Moore MS; Winters A J Public Health Manag Pract; 2022 Mar-Apr 01; 28(2):126-129. PubMed ID: 32956285 [TBL] [Abstract][Full Text] [Related]
9. A Bayesian evidence synthesis approach to estimate disease prevalence in hard-to-reach populations: hepatitis C in New York City. Tan S; Makela S; Heller D; Konty K; Balter S; Zheng T; Stark JH Epidemics; 2018 Jun; 23():96-109. PubMed ID: 29666018 [TBL] [Abstract][Full Text] [Related]
10. Surveillance for chronic hepatitis B virus infection - New York City, June 2008-November 2009. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Jan; 61(1):6-9. PubMed ID: 22237029 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use. Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Perlman DC; Uuskula A; Cooper HLF; Tross S Drug Alcohol Depend; 2018 Nov; 192():74-79. PubMed ID: 30243142 [TBL] [Abstract][Full Text] [Related]
12. Disparities in Zika Virus Testing and Incidence Among Women of Reproductive Age-New York City, 2016. Lee CT; Greene SK; Baumgartner J; Fine A J Public Health Manag Pract; 2018; 24(6):533-541. PubMed ID: 29084118 [TBL] [Abstract][Full Text] [Related]
13. Antiretroviral medication treatment for all HIV-infected individuals: a protocol using innovative multilevel methodologies to evaluate New York City's universal ART policy among problem substance users. Campbell AN; Des Jarlais D; Hannah C; Braunstein S; Tross S; Kersanske L; Borges C; Pavlicova M; Jefferson K; Newville H; Weaver L; Wolff M BMC Health Serv Res; 2016 Aug; 16(a):341. PubMed ID: 27485435 [TBL] [Abstract][Full Text] [Related]
14. A Cost Reimbursement Model for Hepatitis C Treatment Care Coordination. Behrends CN; Eggman AA; Gutkind S; Bresnahan MP; Fluegge K; Laraque F; Litwin AH; Meissner P; Shukla SJ; Perumalswami PV; Weiss J; Wyatt BE; Schackman BR J Public Health Manag Pract; 2019; 25(3):253-261. PubMed ID: 29975342 [TBL] [Abstract][Full Text] [Related]
15. Enhanced chronic hepatitis C surveillance in New York City, April 2009-January 2011. Drezner K; Bornschlegel K; McGibbon E; Balter S Public Health Rep; 2013; 128(6):510-8. PubMed ID: 24179262 [TBL] [Abstract][Full Text] [Related]
16. Health Department Efforts to Increase Hepatitis C RNA Testing Among People Appearing Out of Care: Comparison of Outreach Approaches, New York City, 2017. Webster R; Moore MS; Bocour A; Johnson N; Winters A Public Health Rep; 2020; 135(6):823-830. PubMed ID: 32886566 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis C infection in New York City, 2004. Bornschlegel K; Berger M; Garg RK; Punsalang A; McKinney CM; Gwynn RC; Thorpe LE J Urban Health; 2009 Nov; 86(6):909-17. PubMed ID: 19672718 [TBL] [Abstract][Full Text] [Related]
18. Health department-HIV clinic integration of data and human resources to re-engage out of care HIV-positive persons into clinical care in a New York City locale. Udeagu C; Huang J; Eason L; Pickett L AIDS Care; 2019 Nov; 31(11):1420-1426. PubMed ID: 30821484 [TBL] [Abstract][Full Text] [Related]
19. Validation of a Simplified Laboratory-Based HCV Clearance Definition Using New York City Hepatitis C Program and Surveillance Data. Hwang CS; Montgomery MP; Diaz Munoz DI; Yin S; Teshale EH; Bocour A J Public Health Manag Pract; 2024 Oct; ():. PubMed ID: 39413771 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis C screening beyond CDC guidelines in an Egyptian immigrant community. Perumalswami PV; DeWolfe Miller F; Orabee H; Regab A; Adams M; Kapelusznik L; Aljibawi F; Pagano W; Tong V; Dieterich DT Liver Int; 2014 Feb; 34(2):253-8. PubMed ID: 23890188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]